ARCHIVES

HIPAA Interpretations Vary, Delay Research, ASCO Study Finds

This article is from The Cancer Letter archive.

Vol. 35 No. 30 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

December 25, 2009

NRC Group Splits Over chemical Dose Testing For Carcinogenicity

March 12, 1993

Reader Finds Letter insulting to Ethic Group

February 16, 1996

Postoperative Chemo Doesn’t Improve Survival, Study Finds

March 28, 2008

Solomon Garb’s Questions/Answers

December 19, 1980

Also Kevin Cullen named director, Univ. of Maryland Greenebaum Cancer Center.

November 28, 2003